Doximity (DOCS)
(Delayed Data from NYSE)
$23.82 USD
+0.23 (0.97%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $23.82 0.00 (0.00%) 4:28 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DOCS 23.82 +0.23(0.97%)
Will DOCS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?
Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?
SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?
Other News for DOCS
LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'
Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
Doximity upgraded to neutral at J.P. Morgan but moves to sidelines
Doximity just upgraded at JPMorgan, here's why
6 Analysts Assess Doximity: What You Need To Know